Scope: Develop process improvements and execute production ramp-up for a minimally invasive transcatheter aortic valve replacement.

 

Challenge: Device malfunctioned during validation, so initial design needed to be altered.

 

Outcome: Product attained 510(k) approval after design rework, DFM, and NPI performed at PDV.